EXPERIENCES

COVID-19 Experience

NO. YEAR PHASE STUDY TYPE INDICATION
1 2023 IIT Local COVID-19 Treatment
2 2023 III Local COVID-19 Treatment
3 2023 I Local COVID-19 Vaccine
4 2022 Medical Device Local COVID-19 Diagnostic Kit
5 2022 PMS Local COVID-19 Vaccine
6 2022 III Global COVID-19 Treatment
7 2022 Pilot study Local COVID-19 Treatment
8 2022 I/IIa Local COVID-19 Vaccine
9 2022 III Local COVID-19 Treatment
10 2022 III Global COVID-19 Treatment
11 2021 III Local COVID-19 Treatment
12 2021 Consulting Local COVID-19 Treatment
13 2021 II Local COVID-19 Treatment
14 2021 Consulting Local COVID-19 Treatment
15 2021 II Local COVID-19 Treatment
16 2021 II/III Local COVID-19 Treatment
17 2021 III Global COVID-19 Vaccine
18 2021 Consulting Global COVID-19 Vaccine
19 2021 I/IIa Local COVID-19 Vaccine
20 2021 II/III Global COVID-19 Treatment
21 2021 II Local COVID-19 Treatment
22 2021 I/II Local COVID-19 Treatment
23 2021 II Local COVID-19 Treatment
24 2021 III Local COVID-19 Treatment
25 2021 I/IIa Local COVID-19 Vaccine
26 2021 II Local COVID-19 Treatment
27 2020 I/II Local COVID-19 Vaccine
28 2020 I Local COVID-19 Treatment
29 2020 III Global COVID-19 Vaccine
30 2020 II Local COVID-19 Treatment
31 2020 II Global COVID-19 Treatment
32 2020 II Local COVID-19 Treatment
33 2020 II Local COVID-19 Treatment
34 2020 II Local COVID-19 Treatment
35 2020 I/IIa Local COVID-19 Vaccine
36 2020 I/IIa Local COVID-19 Vaccine
37 2020 Medical Device Local COVID-19 Diagnostic Kit
38 2020 I/IIa Local COVID-19 Treatment
[As of 2023.12.31]
02_04_en Tr e a tment Va c cine Diagno s tic Kit 2520 15 10 5 0

* To overcome the COVID-19 pandemic, LSK Global PS has conducted 25 treatment studies (Global 4, Local 21), 11 vaccine studies (Global 3, Local 8), and 2 diagnostic kit study. (As of December 31th 2023)